NICOLE EARL: Open Payments
NPI 1306985833 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 34 payments from 13 companies in 2025. Trend: 2023 $682 · 2024 $852 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $233 |
| GlaxoSmithKline, LLC. | 6 | $113 |
| PFIZER INC. | 4 | $78 |
| Lilly USA, LLC | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: Ozempic, NURTEC ODT, Wegovy, TRELEGY ELLIPTA, MOUNJARO, SHINGRIX, AUSTEDO XR, VAXNEUVANCE.
Industry payments across MI — which companies pay providers there.
